Literature DB >> 17626073

Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Li Xing1, Elliott Kieff.   

Abstract

Epstein-Barr virus (EBV) microRNAs miR-BHRF1-1, -2, and -3 have been detected in latency III-infected lymphoblasts, where they are encoded within EBNA transcripts (X. Cai, A. Schafer, S. Lu, J. P. Bilello, R. C. Desrosiers, R. Edwards, N. Raab-Traub, and B. R. Cullen, PLoS Pathog. 2:e23, 2006). In latency III-infected lymphoblasts, we have also identified a stable 1.3-kb RNA, which begins 3' to miR-BHRF1-1, includes the BHRF1 open reading frame, and ends near miR-BHRF1-2. This 1.3-kb RNA is the residue of Drosha cleavage of the BHRF1 microRNAs from EBNA transcripts. Early after induction of EBV replication in latency I-infected Akata lymphoblasts, BHRF1 spliced 1.4-kb mRNA accumulated along with low levels of miR-BHRF1-2 and -3 and a 0.9-kb Drosha or miR-BHRF1-2 cleavage product of BHRF1 mRNA. The turning on of latency III infection at 48 to 72 h after induction of EBV replication was associated with higher miR-BHRF1-1, -2, and -3 levels; accumulation of the 1.3-kb RNA residue in the nucleus; abundant BHRF1 spliced 1.4-kb mRNA in the cytoplasm; and more abundant 0.9-kb mRNA cleavage product in the cytoplasm. These findings implicate miR-BHRF1-2 in 3' cleavage of BHRF1 mRNA in the cytoplasm and Drosha in cleavage of latency III EBNA and EBV replication-associated BHRF1 transcripts in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626073      PMCID: PMC2045418          DOI: 10.1128/JVI.02244-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Proteins of purified Epstein-Barr virus.

Authors:  Eric Johannsen; Micah Luftig; Michael R Chase; Steve Weicksel; Ellen Cahir-McFarland; Diego Illanes; David Sarracino; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

2.  Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.

Authors:  Chih-Chung Lu; Yi-Ying Jeng; Ching-Hwa Tsai; Mei-Ying Liu; Sheng-Wen Yeh; Tsuey-Ying Hsu; Mei-Ru Chen
Journal:  Virology       Date:  2005-11-18       Impact factor: 3.616

3.  Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation.

Authors:  Shveta Bagga; John Bracht; Shaun Hunter; Katlin Massirer; Janette Holtz; Rachel Eachus; Amy E Pasquinelli
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.

Authors:  S T Cheung; D P Huang; A B Hui; K W Lo; C W Ko; Y S Tsang; N Wong; B M Whitney; J C Lee
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

6.  Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells.

Authors:  Tatyana A Souza; B David Stollar; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

7.  The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.

Authors:  C Kaiser; G Laux; D Eick; N Jochner; G W Bornkamm; B Kempkes
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Prediction and identification of herpes simplex virus 1-encoded microRNAs.

Authors:  Can Cui; Anthony Griffiths; Guanglin Li; Lindsey M Silva; Martha F Kramer; Terry Gaasterland; Xiu-Jie Wang; Donald M Coen
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs.

Authors:  Xuezhong Cai; Curt H Hagedorn; Bryan R Cullen
Journal:  RNA       Date:  2004-11-03       Impact factor: 4.942

10.  Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma.

Authors:  M Y Liu; Y Y Shih; S P Chou; C J Chen; T S Sheen; C S Yang; J Y Chen
Journal:  J Med Virol       Date:  1998-11       Impact factor: 2.327

View more
  56 in total

Review 1.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 2.  The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.

Authors:  Eleonora Forte; Micah A Luftig
Journal:  Microbes Infect       Date:  2011-07-28       Impact factor: 2.700

Review 3.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.

Authors:  Regina Feederle; Janina Haar; Katharina Bernhardt; Sarah D Linnstaedt; Helmut Bannert; Helge Lips; Bryan R Cullen; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 5.  Viral miRNAs and immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Biochim Biophys Acta       Date:  2011-07-05

Review 6.  Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

Review 7.  The roles of microRNAs in mammalian virus infection.

Authors:  Ralph Grassmann; Kuan-Teh Jeang
Journal:  Biochim Biophys Acta       Date:  2008-05-15

Review 8.  Emergence of a complex relationship between HIV-1 and the microRNA pathway.

Authors:  Dominique L Ouellet; Isabelle Plante; Corinne Barat; Michel J Tremblay; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

Review 9.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

10.  cis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.